Platforms to Identify Candidate Drugs (PICD) Program Workshop

Description

BARDA and VITAL are hosting an interactive, in-person workshop to shape the future of the Platforms to Identify Candidate Drugs (PICD) Program. PICD is a new initiative exploring how AI-driven approaches can incorporate multimodal modeling, biomedical knowledge bases and real-world data to accelerate the identification and prioritization of repurposed (including repositioned, natural products and combination) drug candidates. This workshop will provide stakeholders an opportunity to align on state-of-the-art capabilities, validate assumptions for the vision, and inform a high-impact program. What to Expect Aid in brainstorming AI-driven solutions for drug candidate identification for national health security threats. Through facilitated discussions, breakout sessions, and structured networking, participants will have the opportunity to: Who Should Attend Agenda Breakout Sessions Breakout Session 1: State of the Art and Possibilities (40 min) Breakout Session 2: BARDA's Goals & How We Could Get There (75 min) Agenda subject to changes. Poster Session If you have a technology capability to share that you believe can contribute to PICD, click here to submit a Poster Session Interest Form. Please note: Submitting this poster interest form does not register you for the event. To attend the event, you must request to join using the "Request to Join" button at the top of this page. This does not confirm your participation in the poster session, as there is limited space. You will receive separate confirmation if you are selected to present. Don't miss this rare opportunity. Engage with leading experts to co-create bold, AI-driven approaches with the potential to reshape the future of medical countermeasure development. Please note: Space is limited. Attendance is reserved for approved registrants, and confirmation will be required for entry. About VITAL VITAL is the BARDA Accelerator Network hub supporting development of innovative therapeutic and vaccine solutions for infectious diseases and chemical, biological, radiological, and nuclear threats. VITAL is managed by Start2 Group, with partners Advise Connect Inspire (ACI) and BioLabs. About BARDA Accelerator Network Established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), the BARDA Accelerator Network fosters the growth of health security innovation ecosystems globally and accelerates the development and commercialization of next-generation health security solutions.